Alembic Pharmaceuticals share news and announcements
NSE: APLLTDBSE: 533573Pharmaceuticals & BiotechnologySmall Cap
Last close ₹760.10down ₹21.20 (2.71%)BSE ₹758.75
Share price at the NSE close on 23 Oct 2026. Previous close ₹781.30.
52-week range of traded prices to 23 Oct 2026
₹635.80Low, 23 Mar 2026₹998.00High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹14,941 Cr430th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 4 Aug 2026
- 21.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 2.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.58%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 4 Aug 2026
- 12.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 4 Aug 2026
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 0.24
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,20,84752.2% delivered
Alembic Pharmaceuticals board meetings
105 filed, newest first. Page 1 of 3.
Aug 2026
4 Aug · Board meeting
Jul 2026
May 2026
15 May · Board meeting
Apr 2026
Feb 2026
5 Feb · Board meeting
Jan 2026
Nov 2025
4 Nov · Board meeting
Oct 2025
Aug 2025
5 Aug · Board meeting
Jul 2025
Apr 2025
Feb 2025
3 Feb · Board meeting
Jan 2025
Nov 2024
7 Nov · Board meeting
Oct 2024
Aug 2024
8 Aug · Board meeting
Jul 2024
Apr 2024
Feb 2024
5 Feb · Board meeting
Jan 2024
Oct 2023
Aug 2023
4 Aug · Board meeting
Jul 2023
Apr 2023
Feb 2023
1 Feb · Board meeting
Jan 2023
Oct 2022
Jul 2022
May 2022
Apr 2022
Feb 2022
10 Feb · Board meeting
Jan 2022
Nov 2021
10 Nov · Board meeting
Oct 2021
Jul 2021
26 Jul · Board meeting
Apr 2021
Jan 2021
19 Jan · Board meeting
Oct 2020
22 Oct · Board meeting
Jul 2020
27 Jul · Board meeting
23 Jul · Board meeting
22 Jul · Board meeting
May 2020
22 May · Board meeting
Apr 2020
23 Apr · Board meeting